13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-014003
Total Value
$1.01B
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AXSOME THERAPEUTICS INC | AXSM | 1,468,983 | $124.3M | 12.36% |
| 2 | NUVALENT INC | NUVL | 1,317,664 | $103.1M | 10.25% |
| 3 | SPYRE THERAPEUTICS INC | SYRE | 4,018,101 | $93.5M | 9.30% |
| 4 | APOGEE THERAPEUTICS INC | APGE | 2,048,647 | $92.8M | 9.23% |
| 5 | SCHOLAR ROCK HLDG CORP | SRRK | 1,962,953 | $84.8M | 8.43% |
| 6 | ENLIVEN THERAPEUTICS INC | ELVN | 3,202,798 | $72.1M | 7.16% |
| 7 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,445,813 | $66.1M | 6.57% |
| 8 | ORUKA THERAPEUTICS INC | ORKA | 3,371,922 | $65.4M | 6.50% |
| 9 | DIANTHUS THERAPEUTICS INC | DNTH | 2,700,691 | $58.9M | 5.85% |
| 10 | COGENT BIOSCIENCES INC | COGT | 6,225,641 | $48.6M | 4.83% |
| 11 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 2,194,341 | $43.4M | 4.32% |
| 12 | DAY ONE BIOPHARMACEUTICALS INC | DAWN | 3,103,448 | $39.3M | 3.91% |
| 13 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,554,129 | $31.8M | 3.16% |
| 14 | ANAPTYSBIO INC | ANABV | 1,816,466 | $24.1M | 2.39% |
| 15 | BICARA THERAPEUTICS INC | BCAX | 1,284,169 | $22.4M | 2.22% |
| 16 | INHIBIKASE THERAPEUTICS INC | IKT | 6,125,000 | $19.9M | 1.98% |
| 17 | ZENAS BIOPHARMA INC | ZBIO | 1,892,806 | $15.5M | 1.54% |